SpaceX Stock Is Down 30% From Its Post-IPO High. History Says This Will Happen Next.

SpaceX shares are down ~30% from the $202 mid-June peak to about $140, as investors weigh heavy AI spending and impending lock-up expirations that could lift float from 1.8B to 5.2B shares by early December. Despite a Q2 revenue jump of 92% to $7.8B (AI sales more than tripled), the company burned -$25B free cash flow over H1 2026, implying cash could be depleted in ~2 years if the pace continues. Wall Street’s median 12-month target of $217 suggests 55% upside, but the article’s IPO-history analysis flags potential additional downside of ~15%–36% by June 2027.

Analysis

The key market mechanism here is not “fundamentals vs valuation” so much as a near-term supply shock colliding with a still-unproven cash-generation story. When float expands materially, the marginal price setter shifts from long-term believers to fast money and forced sellers; that usually compresses multiples before it says anything definitive about intrinsic value. In that window, the stock can fall even if revenue stays strong, because public-market investors start discounting dilution, insider distribution, and capex intensity instead of top-line growth.

The second-order effect is on the broader high-multiple growth complex. SPX-like scarcity plus 90x sales creates a read-through to PLTR: if the market starts demanding visible free cash flow rather than “strategic optionality,” names with premium revenue multiples but less balance-sheet flexibility can derate together. NVDA is the cleaner relative beneficiary only if the AI spend is real and persistent; if the market concludes the spend is mostly internal platform buildout with weak near-term monetization, chip suppliers can still trade off as investors reassess the durability of the capex cycle.

The contrarian view is that the historical IPO-average drawdown may be the wrong benchmark for a company with this much strategic scarcity and a deep-pocketed buyer base. The real falsifier is not a chart pattern; it is whether management can show a credible path from revenue growth to FCF inflection before the lock-up overhang clears. If the next print shows accelerating revenue with stabilizing cash burn, the post-lockup selloff thesis weakens materially over 1-3 months; if not, the path of least resistance is lower over the next 1-2 quarters.

For now, this looks more like a tactical short/sell-the-rally setup than a structural short, because any sharp drawdown could attract long-only funds hunting scarce AI exposure. The risk is that the stock remains a “must own” asset and the supply overhang gets absorbed faster than expected.

Key Decisions for Investors

• Initiate a tactical short SPCX or buy 3-6 month put spreads into strength ahead of the next lock-up window; target a 15-25% downside move, with risk capped if the stock reclaims prior highs and holds above that level on volume.
• Use SPCX as a relative-value short against NVDA only if AI capex commentary remains strong; the pair works if the market rewards monetizable infrastructure over capital-intensive platform buildout, but stop out if NVDA re-accelerates on data-center demand.
• Avoid adding to PLTR on this tape; the read-through is that the market may start penalizing premium sales multiples without visible FCF conversion. Falsifier: a clean beat with upward guide and improving cash flow margin.
• Set an alert for post-lock-up trading volume and insider selling pace. If selling clears without a 10-15% additional drawdown, cover tactical shorts because the supply overhang thesis is being absorbed faster than expected.